Jorge T. Gonzalez

Antibody-based therapies against Andes virus: from neutralization to Fc-mediated protection

Abstract Andes virus, the principal etiological agent of hantavirus cardiopulmonary syndrome in South America, is a zoonotic pathogen associated with case fatality rates of up to 40%. Despite its high clinical burden and unique capacity for person-to-person transmission among han...